No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract Progression-Free Survival (PFS) was significantly longer with intensive chemotherapy in patients with advanced stage double or triple hit lymphoma (DHL, THL)

byKathleen Lau

January 7, 2021

in StudyGraphics

RELATED REPORTS

#VisualAbstract: Tarlatamab Improves Survival in Small-Cell Lung Cancer after Platinum-Based Chemotherapy

Sacituzumab tirumotecan may have a role in the treatment of metastatic non-small cell lung cancer

2 Minute Medicine: Pharma Roundup – Perioperative Immunotherapy Efficacy, Expanded Prostate Cancer Indication, Rapid Subcutaneous Myeloma Administration, and Regulatory Compliance Findings [June 4 2025]

Perioperative changes of response to antiplatelet medication in vascular surgery patients

RelatedReports

StudyGraphics

#VisualAbstract: Tarlatamab Improves Survival in Small-Cell Lung Cancer after Platinum-Based Chemotherapy

June 19, 2025

Lessons from real-world implementation of lung cancer screening

AI Roundup

Sacituzumab tirumotecan may have a role in the treatment of metastatic non-small cell lung cancer

June 10, 2025

Pharma

2 Minute Medicine: Pharma Roundup – Perioperative Immunotherapy Efficacy, Expanded Prostate Cancer Indication, Rapid Subcutaneous Myeloma Administration, and Regulatory Compliance Findings [June 4 2025]

June 4, 2025

New genetic link in pulmonary arterial hypertension holds therapeutic promise

Chronic Disease

Hereditary erythrocytosis is associated with a fetal-like EPO isoform

June 2, 2025

#VisualAbstract: Total body skin examinations may aid in the detection of incidental skin cancers in patients with suspicious lesions

#VisualAbstract: Low-dose capecitabine after standard adjuvant therapy improves disease-free survival in patients with early triple-negative breast cancer

Glioblastoma phenotypes identified on MRI predict molecular behavior

Carboplatin as a potential adjunct therapy for recurrent high-grade glioma treatment

#VisualAbstract Fondazione Italiana Linfomi (FIL) Phase 3 trial: Lenalidomide maintenance after autologous haematopoietic stem-cell transplantation (HSCT) in mantle cell lymphoma improves progression-free survival (PFS)

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result